SynOligo Biotechnologies is a Contract Research and Development Organization (CRDO) headquartered in Morrisville, North Carolina (Research Triangle Park), specializing in custom oligonucleotide synthesis. The company provides research, diagnostic, and therapeutic-grade oligonucleotides from nanomole to multi-gram/100+ gram scale. SynOligo handles complex modified oligos including antisense, siRNA, aptamers, CRISPR gRNA, MERFISH probes, and lipid-modified oligos with guaranteed ultra-low endotoxin. The company expanded in 2024 with a new 5,000 sq. ft. high-throughput facility.
custom oligonucleotide synthesis, modified oligo manufacturing, therapeutic oligo production, diagnostic probe synthesis, complex oligo modifications
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.